Latest News about SNY
Recent news which mentions SNY
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
September 16, 2022
From Benzinga
From Benzinga
What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.
September 14, 2022
From Motley Fool
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
September 08, 2022
From Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
September 06, 2022
From Benzinga
From Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Tickers
SNY
From Benzinga
From Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
From Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
August 30, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 25, 2022
From Benzinga
From Benzinga
From Benzinga
The Rise and Fall of Novavax
August 21, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
From Benzinga
From Benzinga
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
August 18, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
From Benzinga
From Benzinga
From MarketWatch
From Benzinga
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
August 17, 2022
From Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
August 12, 2022
From Benzinga
2 Top Biotech Stocks to Buy Right Now
August 12, 2022
From Motley Fool
GSK defends Zantac ahead of trials that have cratered the stock
August 12, 2022
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.